Back
Burford Capital Ltd. Vs. Sarepta Therapeutics, Inc. Industry Stock Comparison
Sell
30
BUR
Burford Capital Ltd.
Last Price:
$9.02
Seasonality Move:
-0.53%
Sell
43
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$21.48
Seasonality Move:
6.08%
Sell
30
Burford Capital Ltd. (BUR)
is a Sell
Is Burford Capital Ltd. a Buy, Sell or Hold?
-
The current Burford Capital Ltd. [BUR] share price is $9.25. The Score for BUR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
BUR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $21.82. The Score for SRPT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BUR Stock Price Chart
What is Burford Capital Ltd.'s stock price today?
-
The Burford Capital Ltd. share price today is $9.25Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BUR is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $21.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
BUR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 50.1 | Buy |
| Chaikin Money Flow: | 1523085 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.01 - 9.39) | Buy |
| Bollinger Bands (100): | (9.23 - 12.93) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.06 | Buy |
| Relative Strength Index (14 RSI): | 54.13 | Buy |
| Chaikin Money Flow: | 1426024 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.03 - 22.43) | Buy |
| Bollinger Bands (100): | (17.92 - 22.36) | Buy |
BUR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.16 | Buy |
| 20-day SMA: | 9.18 | Buy |
| 50-day SMA: | 9.42 | Sell |
| 200-day SMA: | 12.2 | Sell |
| 8-day EMA: | 9.15 | Buy |
| 20-day EMA: | 9.18 | Buy |
| 50-day EMA: | 9.67 | Sell |
| 200-day EMA: | 11.65 | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.5 | Buy |
| 20-day SMA: | 21.62 | Buy |
| 50-day SMA: | 20.75 | Buy |
| 200-day SMA: | 30.1 | Sell |
| 8-day EMA: | 18.84 | Buy |
| 20-day EMA: | 11.91 | Buy |
| 50-day EMA: | 5.9 | Buy |
| 200-day EMA: | 1.65 | Buy |
Burford Capital Ltd. Earnings Growth & BUR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.78 per share, and a decrease next year of $0.00 per share.
Burford Capital Ltd. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||